CH617350A5 - Process for the preparation of HB-Ag vaccines with high-level antibody formation - Google Patents

Process for the preparation of HB-Ag vaccines with high-level antibody formation Download PDF

Info

Publication number
CH617350A5
CH617350A5 CH1636974A CH1636974A CH617350A5 CH 617350 A5 CH617350 A5 CH 617350A5 CH 1636974 A CH1636974 A CH 1636974A CH 1636974 A CH1636974 A CH 1636974A CH 617350 A5 CH617350 A5 CH 617350A5
Authority
CH
Switzerland
Prior art keywords
solution
titer
aqueous solution
vaccines
protein
Prior art date
Application number
CH1636974A
Other languages
German (de)
English (en)
Inventor
Satoshi Funakoshi
Tsunekazu Fukushima
Toshihiko Tanaka
Original Assignee
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp filed Critical Green Cross Corp
Publication of CH617350A5 publication Critical patent/CH617350A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • A61K39/292Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CH1636974A 1974-01-28 1974-12-10 Process for the preparation of HB-Ag vaccines with high-level antibody formation CH617350A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1161774A JPS5523254B2 (fr) 1974-01-28 1974-01-28

Publications (1)

Publication Number Publication Date
CH617350A5 true CH617350A5 (en) 1980-05-30

Family

ID=11782869

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1636974A CH617350A5 (en) 1974-01-28 1974-12-10 Process for the preparation of HB-Ag vaccines with high-level antibody formation

Country Status (6)

Country Link
JP (1) JPS5523254B2 (fr)
CA (1) CA1023662A (fr)
CH (1) CH617350A5 (fr)
DE (1) DE2440926C3 (fr)
FR (1) FR2258864B1 (fr)
GB (1) GB1462298A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
GB1571829A (en) 1976-04-06 1980-07-23 Lafon Labor Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds
JPS591981B2 (ja) * 1976-08-27 1984-01-14 株式会社ミドリ十字 HBs抗体検出用受身赤血球凝集試験用担体の製造方法
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom

Also Published As

Publication number Publication date
JPS50105817A (fr) 1975-08-20
CA1023662A (fr) 1978-01-03
FR2258864A1 (fr) 1975-08-22
DE2440926B2 (de) 1978-04-06
JPS5523254B2 (fr) 1980-06-21
GB1462298A (en) 1977-01-19
DE2440926C3 (de) 1978-11-30
FR2258864B1 (fr) 1978-06-30
DE2440926A1 (de) 1975-07-31

Similar Documents

Publication Publication Date Title
DE2751717C2 (fr)
EP0659767B2 (fr) Procédé de préparation d'un concentré d'immunoglobuline G anti-D et compositions pharmaceutiques qui le contiennent
DE2936047A1 (de) Verfahren zur herstellung eines intravenoes verabreichbaren antikoerperhaeltigen immunglobulinpraeparates und danach hergestellte praeparate
DE2459291A1 (de) Verfahren zur gleichzeitigen herstellung von drei therapeutisch verwendbaren produkten aus einem ausgangsmaterial
CH639854A5 (de) Gefriergetrocknetes natives gammaglobulin-praeparat zur intravenoesen verabreichung und verfahren zu seiner herstellug.
DE2624815B2 (de) Herstellung einer injizierbaren, stromafreien und von Plasmaproteinen freien Hämoglobinlösung
DE2433209A1 (de) Hitzestabile plasmaproteinloesungen, verfahren zu ihrer herstellung und arzneipraeparate
DE2127159A1 (de) Verfahren zur Fraktionierung von Plasmaproteinen
DE2734150C3 (de) Verfahren zur Herstellung von Human-Lysozympräparaten
DE2403994A1 (de) Herstellung von antisera
DE2658170A1 (de) Arzneimittel zur behandlung der durch den hepatitisvirus b ausgeloesten akuten oder chronischen infektionen
DE3152621C2 (fr)
DE2835843A1 (de) Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
CH617350A5 (en) Process for the preparation of HB-Ag vaccines with high-level antibody formation
DE3604947C2 (fr)
DE2440927C3 (de) Injizierbarer inaktivierter Impfstoff gegen Hepatitis B
DE2639012C3 (de) Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen
DE2703620C2 (de) Verfahren zur Herstellung eines Konzentrats des Antihämophiliefaktors
DE19600939C1 (de) Verfahren zur Trennung von IgG und IgA
DE2748520C2 (fr)
DE2515666C3 (de) Piasminreiche Gammaglobulinfraktion, Verfahren zu deren Herstellung und das Verfahrensprodukt enthaltendes Gammaglobulinpräparat
DE2415079C3 (de) Verfahren zum Isolieren von Albumin aus Blutplasma
DE2532276C3 (de) Verfahren zur Reinigung von Human-Antilymphozytenserum
DE2409650A1 (de) Waessrige haptoglobinloesungen, verfahren zu ihrer herstellung und arzneimittel
DE2733923A1 (de) Verfahren zur gewinnung von humanalbumin

Legal Events

Date Code Title Description
PL Patent ceased